Inari Medical
19
6
6
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
10.5%
2 terminated/withdrawn out of 19 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
75%
6 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
The PERSEVERE Study
Role: lead
The PEERLESS II Study
Role: lead
RevCore for In Stent Thrombosis
Role: lead
Inari VISION Registry
Role: lead
ClotTriever® Thrombectomy System Use-Result Survey in Japan
Role: lead
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
Role: lead
The Protrieve PROTECTOR Study
Role: lead
The ArtixASCEND Study
Role: lead
The PEERLESS Study
Role: lead
Validation of SEARCH, a Novel Hierarchical Algorithm to Define Long-term Outcomes After Pulmonary Embolism
Role: collaborator
FlowTriever2 Pulmonary Embolectomy Clinical Study
Role: lead
FlowTriever All-Comer Registry for Patient Safety and Hemodynamics
Role: lead
ClotTriever Outcomes (CLOUT) Registry
Role: lead
FlowTriever for Acute Massive Pulmonary Embolism (FLAME)
Role: lead
Artificial Intelligence to StrategiCally Enhance Pulmonary Embolism Response Team Activation
Role: collaborator
Large-Bore Mechanic Thrombectomy for the Treatment of Symptomatic Portomesenteric Vein Thrombosis
Role: collaborator
Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever
Role: collaborator
Ventilation and Perfusion Scan in Pulmonary Embolism Following Catheter Directed Thrombectomy Versus Anticoagulation Alone
Role: collaborator
FlowTriever Pulmonary Embolectomy Clinical Study
Role: lead
All 19 trials loaded